Hidayat ST

No ORCID on file · 5 papers in corpus · active 2022-2026

Study types

  • article 2
  • other 1
  • review 1

Condition tags

  • endometriosis 3
  • chronic_pelvic_pain 1
other 2026
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.GMIT-D-24-00021

OBJECTIVES: Deep endometriosis (DE) is a common disease in 15%-45% of childbearing-age women. Combined oral contraceptive pill (COCP) and dienogest have been used for decades to treat many forms of endometriosis after laparoscopy surgery. T…

article 2025
Open veterinary journal ·doi:10.5455/ovj.2025.v15.i6.57

BACKGROUND: Andrographolide is a compound that serves as an anti-inflammatory agent. M2 macrophages promote the disease, while M1 macrophages inhibit endometriosis progression. AIM: Andrographolide can modify the M1/M2 ratio, aligning with…

2025
Journal of human reproductive sciences ·doi:10.4103/jhrs.jhrs_7_25

BackgroundGenetic polymorphisms in the luteinizing hormone (LH) β-subunit gene have been associated with responses to controlled ovarian hyperstimulation (COH) in in vitro fertilisation (IVF) patients. Variants in rs1800447 and rs34349826 m…

review 2022
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare10122515

This work provides consensus guidance regarding clinical diagnosis and early medical management of endometriosis within Asia. Clinicians with expertise in endometriosis critically evaluated available evidence on clinical diagnosis and early…

article 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00787-w

Several clinical trials in women with endometriosis demonstrated that dienogest reduces endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL in dienogest-treated patients in real-world setting, we conduct…